Elevance Health Cash Flow Statement
ELV / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Elevance Health generated $4.3B in operating cash flow and $3.2B in free cash flow in FY2025. Free cash flow margin was 1.6% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $5.7B | $6.0B | $6.2B | $5.9B | $4.8B | $4.6B | $4.8B | $3.8B | $3.8B | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B | $2.6B |
| Depreciation & Amortization | $94.0M | - | $136.0M | - | $147.0M | $176.0M | - | $124.0M | - | $104.0M | - | $106.5M | $107.9M | $107.1M | - |
| Operating Cash Flow | $4.3B | $5.8B | $8.4B | $8.4B | $6.1B | $10.7B | $6.1B | $3.8B | $4.2B | $3.3B | $4.2B | $3.4B | $3.1B | $2.7B | $3.4B |
| Capital Expenditures | $1.1B | $1.3B | $1.1B | $1.2B | $1.1B | $1.0B | $1.1B | $1.2B | $791.0M | $584.0M | $638.2M | $714.6M | $646.5M | $544.9M | $519.5M |
| Free Cash Flow | $3.2B | $4.6B | $7.3B | $7.2B | $5.0B | $9.7B | $5.0B | $2.6B | $3.4B | $2.7B | $3.6B | $2.7B | $2.4B | $2.2B | $2.9B |
| Share Buybacks | $2.6B | $2.9B | $1.9B | $2.3B | $1.7B | $2.7B | $1.7B | $1.7B | $2.0B | $0 | $1.5B | $3.0B | $1.6B | $2.5B | $3.0B |
| Dividends Paid | $1.5B | $378.0M | $1.1B | $1.2B | $818.0M | $954.0M | $818.0M | $776.0M | $705.0M | $684.0M | $656.6M | $480.7M | $448.0M | $367.1M | $357.8M |
| FCF Margin | 1.6% | 2.6% | 5.3% | 4.6% | 4.8% | 7.9% | 4.8% | 2.8% | 3.8% | 3.2% | 4.5% | 3.6% | 3.4% | 3.6% | 4.7% |